Home   /   Pressrelease    /    Share warrant program fully su...

Share warrant program fully subscribed

XVIVO Perfusion AB's share warrant program 2016/2018 is fully subscribed. A total of 212,000 warrants with the right to subscribe for new shares were issued. Each warrant has in June 2018 the right to subscribe for one new share at a price of SEK 90.22.

The annual shareholder meeting May 3, 2016 approved the warrant program of a maximum of 212,000 warrants to be offered to employees in XVIVO Perfusion. Upon full exercise of the warrants, the share capital increase is around SEK 5,500 corresponding to a dilution of about 0.9 percent of the total number of shares and votes.

Magnus Nilsson, CEO of XVIVO Perfusion: “The broad support is very encouraging and it gives all of our employees a stronger shareholder interest and an even stronger incentive to fulfill our goals.”

July 8, 2016 
Gothenburg
XVIVO Perfusion AB (publ)

Fill out the form to watch the video